특허 및 논문

Check out the archives at Biosolvix.
bt_bb_section_bottom_section_coverage_image

BIOSOLVIX ARCHIVE특허 및 논문

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy.

Author
관리자
Date
2024-02-02 08:33
Views
367
Yun-Gwi Park, Yeo-Jin Son, Sung-Hwan Moon and Soon-Jung Park*. In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy. J Anim Reprod Biotechnol. 2022;37:67-79. *Review

 

Abstract

Currently, there is no treatment to reverse or cure heart failure caused by ischemic heart disease and myocardial infarction despite the remarkable advances in modern medicine. In addition, there is a lack of evidence regarding the existence of stem cells involved in the proliferation and regeneration of cardiomyocytes in adult hearts. As an alternative solution to overcome this problem, protocols for differentiating human pluripotent stem cell (hPSC) into cardiomyocyte have been established, which further led to the development of cell therapy in major leading countries in this field. Recently, clinical studies have confirmed the safety of hPSC-derived cardiac progenitor cells (CPCs). Although several institutions have shown progress in their research on cell therapy using hPSC-derived cardiomyocytes, the functions of cardiomyocytes used for transplantation remain to be those of immature cardiomyocytes, which poses a risk of graft-induced arrhythmias in the early stage of transplantation. Over the last decade, research aimed at achieving maturation of immature cardiomyocytes, showing same characteristics as those of mature cardiomyocytes, has been actively conducted using various approaches at leading research institutes worldwide. However, challenges remain in technological development for effective generation of mature cardiomyocytes with the same properties as those present in the adult hearts. Therefore, in this review, we provide an overview of the technological development status for maturation methods of hPSC-derived cardiomyocytes and present a direction for future development of maturation techniques.




Keywords: #cardiomyocyte #cell therapy #human pluripotent stem cell #maturation #safety

 


논문확인(클릭시 이동) 
Total 52
Number Title Author Date Votes Views
52
[특허] 콘케이브와 진탕배양 기법으로 형성된 전분화능 줄기세포 유래 신경세포 제조방법 및 이에 의해 제조된 3D 신경 오가노이드를 통한 약물 독성 평가방법
관리자 | 2024.02.22 | Votes 0 | Views 252
관리자 2024.02.22 0 252
51
[특허] 중간엽줄기세포 패치 공배양 기법을 이용한 투명 배상체 유래 간세포 제조방법 및 이에 의해 제조된 3D 간 오가노이드를 통한 약물 독성 평가방법
관리자 | 2024.02.22 | Votes 0 | Views 274
관리자 2024.02.22 0 274
50
[특허] 인간 전분화능 줄기세포로 유래된 심장 오가노이드 제조방법, 효능 및 독성 평가 기술
관리자 | 2024.02.22 | Votes 0 | Views 306
관리자 2024.02.22 0 306
49
[특허] 인공 신경망을 이용한 심장 부정맥 유발약물의 스크리닝 방법
관리자 | 2024.02.20 | Votes 0 | Views 313
관리자 2024.02.20 0 313
48
[특허] 3 차원 세포 배양용 미세유체칩 및 이를 이용한 3 차원 세포 배양방법
관리자 | 2024.02.20 | Votes 0 | Views 281
관리자 2024.02.20 0 281
47
Translation reinitiating in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant neg
관리자 | 2024.02.02 | Votes 0 | Views 279
관리자 2024.02.02 0 279
46
Extracellular matrix cues regulate the differentiation of pluripotent stem cell-derived endothelial cells.
관리자 | 2024.02.02 | Votes 0 | Views 336
관리자 2024.02.02 0 336
45
Ultraefficient extracellular vesicle–guided direct reprogramming of fibroblasts into functional cardiomyocytes.
관리자 | 2024.02.02 | Votes 0 | Views 355
관리자 2024.02.02 0 355
44
In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy.
관리자 | 2024.02.02 | Votes 0 | Views 367
관리자 2024.02.02 0 367
43
Enhancement strategy for effective vascular regeneration following myocardial infarction through a dual stem cell approach.
관리자 | 2024.02.02 | Votes 0 | Views 311
관리자 2024.02.02 0 311